TUMOR-TREATING-FIELD (TTFIELD) EFFECTS ON GLIOBLASTOMA CELLS ARE AUGMENTED BY MITOTIC CHECKPOINT INHIBITION

被引：0
|
作者：
Kessler, Almuth F. [1 ]
Froembling, Greta Eliza [1 ]
Gross, Franziska [1 ]
Ernestus, Ralf-Ingo [1 ]
Loehr, Mario [1 ]
Hagemann, Carsten [1 ]
机构：
[1] Univ Hosp Wuerzburg, Dept Neurosurg, Tumorbiol Lab, Wurzburg, Germany
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-07
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [31] THE EFFECTS OF PLANT MITOTIC INHIBITORS ON MAMMALIAN TUMOR-CELLS
    ZILKAH, S
    OSBAND, M
    MCCAFFREY, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 270 - 270
  • [32] z-Leucinyl-Leucinyl-Norleucinal Induces Apoptosis of Human Glioblastoma Tumor-initiating Cells by Proteasome Inhibition and Mitotic Arrest Response
    Monticone, Massimiliano
    Biollo, Emanuela
    Fabiano, Andrea
    Fabbi, Marina
    Daga, Antonio
    Romeo, Francesco
    Maffei, Massimo
    Melotti, Alice
    Giaretti, Walter
    Corte, Giorgio
    Castagnola, Patrizio
    MOLECULAR CANCER RESEARCH, 2009, 7 (11) : 1822 - 1834
  • [33] Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts
    Falchetti, Maria Laura
    Mongiardi, Maria Patrizia
    Fiorenzo, Paolo
    Petrucci, Giovanna
    Pierconti, Francesco
    D'Agnano, Igea
    D'Alessandris, Giorgio
    Alessandri, Giulio
    Gelati, Maurizio
    Ricci-Vitiani, Lucia
    Maira, Giulio
    Larocca, Luigi Maria
    Levi, Andrea
    Pallini, Roberto
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (06) : 1236 - 1242
  • [34] The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells
    Clark, Paul A.
    Gaal, Jordan T.
    Strebe, Joslyn K.
    Pasch, Cheri A.
    Deming, Dustin A.
    Kuo, John S.
    Robins, H. Ian
    JOURNAL OF CLINICAL NEUROSCIENCE, 2017, 36 : 120 - 124
  • [35] Tumor-Inhibition Effect of Levetiracetam in Combination with Temozolomide in Glioblastoma Cells
    Marutani, A.
    Nakamura, M.
    Nishimura, F.
    Nakazawa, T.
    Matsuda, R.
    Hironaka, Y.
    Nakagawa, I.
    Tamura, K.
    Takeshima, Y.
    Motoyama, Y.
    Boku, E.
    Ouji, Y.
    Yoshikawa, M.
    Nakase, H.
    NEUROCHEMICAL JOURNAL, 2017, 11 (01) : 43 - 49
  • [36] Tumor-inhibition effect of levetiracetam in combination with temozolomide in glioblastoma cells
    A. Marutani
    M. Nakamura
    F. Nishimura
    T. Nakazawa
    R. Matsuda
    Y. Hironaka
    I. Nakagawa
    K. Tamura
    Y. Takeshima
    Y. Motoyama
    E. Boku
    Y. Ouji
    M. Yoshikawa
    H. Nakase
    Neurochemical Journal, 2017, 11 : 43 - 49
  • [37] TUMOR TREATING FIELDS IN COMBINATION WITH THE TERT-INHIBITOR ERIBULIN HAVE SYNERGISTIC ANTIPROLIFERATIVE EFFECTS ON HUMAN GLIOBLASTOMA CELLS
    Stein, Marco
    Beusker, Piet
    Goett, Hanna
    Kolodziej, Malgorzata
    Uhl, Eberhard
    NEURO-ONCOLOGY, 2021, 23 : 164 - 164
  • [38] The combination of tumor treating fields and hyperthermia has synergistic therapeutic effects in glioblastoma cells by downregulating STAT3
    Jo, Yunhui
    Han, Young In
    Lee, Eunjun
    Seo, Jaehyeon
    Oh, Geon
    Sung, Heehun
    Gi, Yongha
    Kim, Hyunwoo
    Park, Sangmin
    Yoon, Myonggeun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (03): : 1423 - 1432
  • [39] PROSTAGLANDIN E RECEPTOR 3 MEDIATES RESISTANCE TO TUMOR TREATING FIELDS IN GLIOBLASTOMA CELLS
    Chen, Dongjiang
    Le, Son
    Thomas, Nagheme
    Tran, David
    NEURO-ONCOLOGY, 2019, 21 : 72 - 72
  • [40] Prostaglandin E receptor 3 mediates resistance to tumor treating fields in glioblastoma cells
    Chen, Dongjiang
    Le, Son
    Thomas, Nagheme
    Deng, Changwang
    Jin, Dan
    Sebstian, Mathew
    Ren, Jie
    Tran, David
    CANCER RESEARCH, 2019, 79 (13)
12345